Delivery Order SPE2DB20D1100-SPE2DB25FC6S5

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $4.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $30,259.80 contract is for the supply of Trulicity 3 mg/0.5 ml pens, a diabetes treatment medication. The award has an ultimate completion date of May 2, 2025. This contract is not set aside and represents an open competition award. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a $5,761.04 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1.5 mg/0.5 ml Trulicity pens, a drug used to treat diabetes. The award has an ultimate completion date of May 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a $2,493.44 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 4.5 mg/0.5 ml pens, a medication used for diabetes management. The order has an ultimate completion date of October 22, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a large $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical to...
This is a $6,730.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,201,488 units of the diabetes medication Trulicity 3 mg/0.5 ml pens. The award has a period of performance through May 12, 2025 and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a $1,801.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has an ultimate completion date of May 22, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a $5,699.54 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to the corporate office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 3 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of May 15, 2024 and is not set aside for any specific business type. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery...
This is a $3,453.49 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used for the treatment of diabetes. The contract has an ultimate completion date of November 28, 2023 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a larger $999,999,999...
This is a $8,582.01 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the drug Trulicity 3 mg/0.5 ml pens, which are used to treat diabetes. The order has an ultimate completion date of November 28, 2023. The contract is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 4.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a total ceiling value of $1,801.80 and a period of performance through May 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,065.30 firm fixed-price contract is for the supply of Trulicity 3 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of April 22, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC6S5
    Delivery Order

This is a $4,504.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 3 mg/0.5 mL pens, a medication used to treat diabetes. The contract has an ultimate completion date of June 4, 2025 and does not have a set-aside designation, indicating it was open to full and open competition.

AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/2/25, 9:55 AM